Bill FReeman

Dr. Bill FReeman

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in BioTechniques
Verified
Journal Article
Open access
HVHeather D. VanGuilder
Heather D. VanGuilder
KVKent Vrana
Kent Vrana
BFBill FReeman
Bill FReeman
Following its invention 25 years ago, PCR has been adapted for numerous molecular biology applications. Gene expression analysis by reverse-transcription quantitative PCR (RT-qPCR) has been a key enabling technology of the...

1 January 1999 in BioTechniques
Verified
Journal Article
Open access
BFBill FReeman
Bill FReeman
SWStephen J. Walker
Stephen J. Walker
KVKent Vrana
Kent Vrana
Reverse transcription PCR (RT-PCR) represents a sensitive and powerful tool for analyzing RNA. While it has tremendous potential for quantitative applications, a comprehensive knowledge of its tech...

1 September 2006 in Diabetes
Verified
Journal Article
Open access
PDF file
DADavid Antonetti
David Antonetti
ABAlistair J. Barber
Alistair J. Barber
SBSarah K. Bronson
Sarah K. Bronson
BFBill FReeman
Bill FReeman
TGThomas Gardner
Thomas Gardner
FGfor the JDRF Diabetic Retinopathy Center Group
for the JDRF Diabetic Retinopathy Center Group
Diabetic retinopathy remains a frightening prospect to patients and frustrates physicians. Destruction of damaged retina by photocoagulation remains the primary treatment nearly 50 years after its introduction. The diabetes pandemic requires new approaches to understand the pathophysiology and improve the detection, prevention, and treatment of retinopathy. This perspective considers how the unique anatomy and physiology of the retina may predispose it to the metabolic stresses of diabetes. The roles of neural retinal alterations and impaired retinal insulin action in the pathogenesis of early retinopathy and the mechanisms of vision loss are emphasized. Potential means to overcome limitations of current animal models and diagnostic testing are also presented with the goal of accelerating therapies to manage retinopathy in the face of ongoing diabetes.

10 January 2024 in Nature Aging
Verified
Journal Article
Open access
PDF file
JIJosé V. V. Isola
José V. V. Isola
SOSarah R. Ocañas
Sarah R. Ocañas
CHChase R. Hubbart
Chase R. Hubbart
SKSunghwan Ko
Sunghwan Ko
SMSamim Ali Mondal
Samim Ali Mondal
MSMichael B. Stout
Michael B. Stout
Ovarian aging leads to diminished fertility, dysregulated endocrine signaling and increased chronic disease burden. These effects begin to emerge long before follicular exhaustion. Female humans experience a sharp decline in fertility around 35 years of age, which corresponds to declines in oocyte quality. Despite a growing body of work, the field lacks a comprehensive cellular map of the transcriptomic changes in the aging mouse ovary to identify early drivers of ovarian decline. To fill this gap we performed single-cell RNA sequencing on ovarian tissue from young (3-month-old) and reproductively aged (9-month-old) mice. Our analysis revealed a doubling of immune cells in the aged ovary, with lymphocyte proportions increasing the most, which was confirmed by flow cytometry. We also found an age-related downregulation of collagenase pathways in stromal fibroblasts, which corresponds to rises in ovarian fibrosis. Follicular cells displayed stress-response, immunogenic and fibrotic signaling pathway inductions with aging. This report provides critical insights into mechanisms responsible for ovarian aging phenotypes. The data can be explored interactively via a Shiny-based web application.

18 December 2009 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Closed access
PDF file
RARajeshwara Achur
Rajeshwara Achur
BFBill FReeman
Bill FReeman
KVKent Vrana
Kent Vrana

21 July 2017 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
CMColleen Mangold
Colleen Mangold
BWBenjamin Wronowski
Benjamin Wronowski
MDMei Du
Mei Du
DMDustin R. Masser
Dustin R. Masser
NHNiran Hadad
Niran Hadad
BFBill FReeman
Bill FReeman
The necessity of including both males and females in molecular neuroscience research is now well understood. However, there is relatively limited basic biological data on brain sex differences across the lifespan despite the differences in age-related neurological dysfunction and disease between males and females. Whole genome gene expression of young (3 months), adult (12 months), and old (24 months) male and female C57BL6 mice hippocampus was analyzed. Subsequent bioinformatic analyses and confirmations of age-related changes and sex differences in hippocampal gene and protein expression were performed. Males and females demonstrate both common expression changes with aging and marked sex differences in the nature and magnitude of the aging responses. Age-related hippocampal induction of neuroinflammatory gene expression was sexually divergent and enriched for microglia-specific genes such as complement pathway components. Sexually divergent C1q protein expression was confirmed by immunoblotting and immunohistochemistry. Similar patterns of cortical sexually divergent gene expression were also evident. Additionally, inter-animal gene expression variability increased with aging in males, but not females. These findings demonstrate sexually divergent neuroinflammation with aging that may contribute to sex differences in age-related neurological diseases such as stroke and Alzheimer’s, specifically in the complement system. The increased expression variability in males suggests a loss of fidelity in gene expression regulation with aging. These findings reveal a central role of sex in the transcriptomic response of the hippocampus to aging that warrants further, in depth, investigations.